心脏淀粉样变:现在与未来

Cardiac amyloidosis: the present and the future

随着影像技术的进步和有效治疗手段的不断涌现,心脏淀粉样变近年来备受关注。在当前临床实践中,仍存在对心脏淀粉样变认识不足、诊断技术普及率低、漏诊率和延迟诊断率高等问题。提高早期识别率、规范诊断流程、选择合理治疗方法对改善心脏淀粉样变的预后有重要意义。同时,临床上尚存在未满足的需求,亟待我们去探索和解决。

With the advancement of imaging technology and the emergence of effective treatment methods,cardiac amyloidosis has received much attention in recent years.However,in current domestic clinical practice,there are still problems such as insufficient understanding,low prevalence of diagnostic techniques,high rates of missed and delayed diagnosis.Improving the early recognition rate,standardizing the diagnostic process,and selecting reasonable treatment methods are important for improving the prognosis of cardiac amyloidosis.At the same time,there are still unmet clinical needs that need to be explored and solved.